64
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T12181 |
NaV1.7 inhibitor-1
|
Sodium Channel | Membrane transporter/Ion channel |
NaV1.7 inhibitor-1 是有效的、选择性的电压门控钠通道 (Nav) 1.7 抑制剂,对于hNaV1.7的IC50为 0.6 nM,其选择性是 hNaV1.5 的 80 倍。 | |||
T38911 |
Nav1.7-IN-8
Nav1.7-IN-8 |
||
Nav1.7-IN-8 is a highly potent and selective inhibitor of NaV1.7, exhibiting greater selectivity for inhibiting NaV1.7 compared to the subtypes hNaV1.1 and hNaV1.5. Additionally, Nav1.7-IN-8 has inhibitory effects on CYP2C9 and CYP3A4, with IC50 values of 0.17 μM and 0.077 μM, respectively. Notably, Nav1.7-IN-8 demonstrates significant analgesic properties in rodent models of both acute and inflammatory pain. | |||
T12184 | Nav1.7 inhibitor | Others | Others |
Nav1.7 inhibitor is a potent inhibitor of Nav1.7. | |||
T28132 |
NaV1.7 Blocker-801
|
||
NaV1.7 Blocker-801 is a potent NaV1.7 blocker. | |||
T12180 | Nav1.7-IN-6 | Others | Others |
Nav1.7-IN-6, a selective inhibitor of Nav1.7. | |||
T12183 | Nav1.7-IN-3 | Others | Others |
Nav1.7-IN-3 is a selective and orally bioavailable inhibitor of voltage-gated sodium channel Nav1.7(IC50 of 8 nM). | |||
T12182 | Nav1.7-IN-2 | Others | Others |
Nav1.7-IN-2 is avoltage-gated sodium channels (Nav) inhibitor in particular Nav 1.7(IC50 of 80 nM). | |||
T8711 |
PF-05186462
PF-05150122 |
Sodium Channel | Membrane transporter/Ion channel |
PF-05186462 (PF-05150122)是选择性的人Nav1.7电压依赖性钠通道抑制剂,IC50为 21 nM,与其他钠通道 (Nav 1.1、1.2、1.3、1.4、1.5、1.6 和 1.8) 相比,它对 Nav1.7显示出显著的选择性。PF-05186462在急性或慢性疼痛中具有研究价值。 | |||
T7336 |
ICA-121431
2,2-Diphenyl-N-[4-(thiazol-2-ylsulfamoyl |
Sodium Channel | Membrane transporter/Ion channel |
ICA-121431 (2,2-Diphenyl-N-[4-(thiazol-2-ylsulfamoyl) 是强效的、广谱的电压门控钠通道阻滞剂,对人 Nav1.1 和 Nav1.3 亚型具有等效选择性,IC50分别为 13 nM 和 23 nM。它对Nav1.2 的抑制作用较弱,IC50为240 nM,对 Nav1.4、Nav1.6、抗TTX 的人 Nav1.5、Nav1.8 通道表现出大于 1000 倍的选择性,IC50>10 μM。 | |||
T12655 |
(Rac)-AMG8379
(Rac)-AMG8380 |
Sodium Channel | Membrane transporter/Ion channel |
(Rac)-AMG8379 ((Rac)-AMG8380) 是 AMG8379 的外消旋体,是一种具有口服活性和选择性的磺胺 NaV1.7 拮抗剂。 | |||
TQ0014 |
GNE-131
|
Sodium Channel | Membrane transporter/Ion channel |
GNE-131 是有效的人类钠离子通道 NaV1.7(hNaV1.7)选择性抑制剂,IC50为 3 nM。 | |||
T7502 |
PF 05089771 tosylate
|
Sodium Channel | Membrane transporter/Ion channel |
PF 05089771 tosylate 是口服有效的、选择性的Nav1.7丙烯酰胺抑制剂。PF 05089771 tosylate 具有用于疼痛和糖尿病神经性疾病的研究。 | |||
T9685 |
DS-1971a
|
Sodium Channel | Membrane transporter/Ion channel |
DS-1971a 是选择性、口服有效的 NaV1.7抑制剂,对 hNaV1.7 和 mNaV1.7 的 IC50分别为 22.8 和 59.4 nM。DS-1971a 在缓解疼痛方面有研究价值。 | |||
T23439 |
TC-N 1752
|
Sodium Channel | Membrane transporter/Ion channel |
TC-N 1752 是一种具有口服活性的 Nav1.7 通道抑制剂,IC50 为 0.17 μM。 TC-N 1752 显示镇痛活性。 | |||
T17263 |
XEN907
|
Others | Others |
XEN907 is a novel spiro oxindole NaV1.7 blocker. XEN907 also inhibits hNaV1.7 (IC50: 3 nM). | |||
T7502L |
PF 05089771
PF-05089771,PF05089771 |
Sodium Channel | Membrane transporter/Ion channel |
PF 05089771是具有口服有效的、选择性的 Nav1.7丙烯酰胺抑制剂。PF-05089771在疼痛和糖尿病神经性疾病的研究中具有价值。 | |||
T62000 |
ABBV-318
|
||
ABBV-318可被当作治疗疼痛的小分子Nav1.7/ Nav1.8阻滞剂,对hNav1.7 和 hNav1.8具有抑制作用 , IC50 值分别为 2.8 μM 和 3.8 μM。ABBV-318 可以用于研究与疼痛相关的疾病。 | |||
T9461 |
AZ194
|
Sodium Channel | Membrane transporter/Ion channel |
CRMP2-Ubc9-NaV1.7 inhibitor 194 是一流的CRMP2-Ubc9相互作用抑制剂及NaV1.7抑制剂 (IC50=1.2 μM),口服有活性,具有抗伤害作用。AZ194 阻断 CRMP2 的 SUMOylation 以选择性地减少表面表达 NaV1.7 的量。 | |||
T50030 |
1-(2,4-difluorophenyl)guanidine hydrochloride
|
Others | Others |
1-(2,4-difluorophenyl)guanidine hydrochloride 是一种化合物,是电压门控钠通道Nav1.7的强效选择性抑制剂,Nav1.7是疼痛信号传输的关键参与者,因此它能够减少疼痛信号的传递,从而产生镇痛作用。 | |||
T9647 |
GX 201
GX-201 |
Sodium Channel | Membrane transporter/Ion channel |
GX 201 是选择性的 NaV1.7 抑制剂,其对 hNaV1.7 的 IC50 值为 <3.2 nM。 | |||
T15174 |
DSP-2230
|
Sodium Channel | Membrane transporter/Ion channel |
DSP-2230 是有效的Nav1.7/Nav1.8通道选择性阻断剂。 | |||
T15358 |
Funapide
TV 45070,XEN402 |
Sodium Channel | Membrane transporter/Ion channel |
Funapide (TV 45070) 是一个有效的钠通 Nav1.7 抑制剂,据有潜在的抗炎活性,可用来治疗红斑性肢痛症、肌肉骨骼疼痛、膝关节炎以及疱疹后神经。 | |||
T34081 |
Piromelatine
NEU-P-11,NEU-P 11,NEU-P11 |
P2X Receptor; 5-HT Receptor; MT Receptor; Sodium Channel; TRP/TRPV Channel | GPCR/G Protein; Membrane transporter/Ion channel; Neuroscience |
Piromelatine 是褪黑激素 MT1/MT2 受体、5-HT1A 和 5-HT1D 的激动剂,也是 5-HT2B 的拮抗剂。Piromelatine 具有抗痛觉活性,对 P2X3、TRPV1 和 Nav1.7 通道有抑制作用,可用于促进睡眠、缓解疼痛、抗神经退行性疾病和抗抑郁疾病的研究。 | |||
T2342 |
Raxatrigine
CNV1014802,CNV 1014802,GSK-1014802,CNV-1014802 |
Sodium Channel | Membrane transporter/Ion channel |
Raxatrigine (CNV 1014802) 是有效的钠离子通道 Nav1.7抑制剂。 | |||
T24520 |
NAV26
NAV-26,NAV 26 |
||
NAV26 is a selective blocker of the Nav1.7 channel. | |||
T16487 |
PF-05241328
|
Others | Others |
PF-05241328 is an effective and selective inhibitor of human Nav1.7 voltage-dependent sodium channels (IC50: 31 nM). | |||
T11439 | GNE-616 | Others | Others |
GNE-616 is a highly potent, metabolically stable, orally bioavailable, and subtype-selective Nav1.7 inhibitor (Ki: 0.79 nM, Kd: 0.38 nM for hNav1.7) for the treatment of chronic pain. | |||
T14201 |
AM-2099
|
Others | Others |
AM-2099 is a voltage-gated sodium channel Nav1.7 inhibitor (IC50: 0.16 μM). | |||
T71166 |
PF-05150122
|
||
PF-05150122 is a novel potent and selective human Nav1.7 blocker. | |||
T11437 |
GNE-0439
|
Others | Others |
GNE-0439 is a novel Nav1.7-selective inhibitor (IC50: 0.34 uM) and inhibits Nav1.5 (IC50: 38.3 μM). GNE-0439 inhibits mutant N1742K channels (IC50: 0.37 uM) in membrane potential assays. | |||
T27521 |
GX-936
GX 936,PF 05196233,PF05196233,GX936,PF-05196233 |
||
GX-936, a Nav1.7 inhibitor, inhibits Nav1.7 through a voltage-sensor trapping mechanism, likely by stabilizing inactivated states of the channel. | |||
T27520 |
GX-395
GX 395 |
||
GX-395 is a novel Nav1.7 inhibitor. | |||
T22829 |
GX-674
|
Sodium Channel | Membrane transporter/Ion channel |
GX-674 是一种具有高效和选择性的电压门控钠通道 1.7 (Nav1.7) 拮抗剂,在 -40 mV 时测得 IC50 值为 0.1 nM,可用于研究炎症和神经性疼痛。 | |||
T33943 |
PF-04856264
PF-4856264,PF4856264,PF 4856264 |
||
PF-04856264 is a potent and selective human Nav1.7 voltage-gated sodium channel inhibitor (IC50 = 28 nM). | |||
T16485 |
PF-05198007
|
Others | Others |
PF-05198007 is a compound with a similar pharmacodynamic profile to PF-05089771. PF-05198007 is an effective and selective arylsulfonamide Nav1.7 inhibitor. | |||
T14992 |
Raxatrigine hydrochloride
GSK-1014802 hydrochloride,CNV1014802 (hydrochloride) |
Others | Others |
Raxatrigine hydrochloride is a state-dependent sodium channel blocker and a Nav1.7 sodium channel inhibitor. | |||
T80042 |
GpTx-1
|
Sodium Channel | Membrane transporter/Ion channel |
GpTx-1作为NaV1.7选择性抑制剂,具有高效性,其半抑制浓度(IC50)为10 nM。 | |||
T28371 |
PF-06456384
PF 6456384,PF06456384,PF6456384,PF 06456384,PF-6456384 |
||
PF-06456384 is a highly potent and selective NaV1.7 inhibitor with IC50 value of 0.01 nM. | |||
T11377 |
GDC-0276
|
Others | Others |
GDC-0276, a potent, selective, reversible, and orally active NaV1.7 inhibitor with an IC50 value of 0.4 nM, offers potential for pain treatment while overcoming limitations associated with current pain medications, including addiction and off-target side effects. It is well tolerated and demonstrates a favorable pharmacokinetic profile. | |||
TP2070 |
BDS I
|
||
Potent and reversible Kv3.4 potassium channel blocker (IC50 = 47 nM); also attenuates inactivation of sodium currents by acting on Nav1.7 and Nav1.3 channels. Enhances TTX-sensitive sodium currents in rat small dorsal root ganglion neurons. Neuroprotective. | |||
T75250 | (R)-Funapide | ||
(R)-Funapide ((R)-TV 45070)为Funapide中活性较低的R-对映异构体,是一种高效的Nav1.7钠通道阻滞剂,应用于疼痛研究。 | |||
T80444 |
Phlo1b
μ-TrTx-Phlo1b |
Sodium Channel | Membrane transporter/Ion channel |
Phlo1b(μ-TrTx-Phlo1b)为含35个氨基酸残基的肽毒素,特异性抑制Nav1.7通道。相较之下,其对Nav1.2与Nav1.5的抑制作用较弱。 | |||
T69915 |
GX-585
|
||
GX-585 is a novel potent inhibitor of NaV1.7 and highly selective against NaV1.5, having limited selectivity against NaV1.1 and NaV1.2. | |||
T80450 |
Pe1b
μ-TrTx-Pe1b |
Sodium Channel | Membrane transporter/Ion channel |
Pe1b (μ-TrTx-Pe1b) 作为选择性Nav1.7抑制剂,展现出IC50为167 nM的活性。 | |||
TP1680 |
ProTx II
|
||
Selective NaV1.7 channel blocker. Shifts activation gating positively and decreases current magnitude. Displays 100-fold selectivity over other sodium channel subtypes. | |||
T80435 |
Heteropodatoxin-1
|
Potassium Channel | Membrane transporter/Ion channel |
Heteropodatoxin-1 (HpTx1)为蜘蛛肽毒素,主要作用为Kv4.2电流的抑制剂,同时能够抑制Nav1.7和激活Nav1.9, 但对Nav1.8无影响。 | |||
T79398 |
Ancistrotecine B
|
Sodium Channel | Membrane transporter/Ion channel |
Ancistrotecine B(化合物2)为Nav1.7通道抑制剂(IC50:0.73 μM),能减轻小鼠炎症所致疼痛。 | |||
T69728 |
SUN49199
|
||
SUN49199, also known as NaV1.7 Blocker-13, is a novel selective blocker of NaV1.7 with little affinity for NaV 1.2, 1.3, or 1.6, being more potent at human vs guinea pig NaV1.7. SUN49199 was reported in Journal of Pharmacology and Experimental Therapeutics (2017), 361(1), 172-180. This product has no formal name at the moment. For the convenience of communication, a temporary code name was therefore proposed according to MedKoo Chemical Nomenclature (see web page: https://www.medkoo.com/page/na... | |||
TP2016 |
Huwentoxin-IV
Huwentoxin IV |
||
Selective NaV1.7 channel blocker. Preferentially inhibits neuronal NaV1.7, 1.2 and 1.3 (IC50 values are 26, 150 and 338 nM respectively), compared to muscle subtypes NaV1.4 and 1.5 (IC50 = >10 μM). Inhibits the channel by binding at the neurotoxin recepto | |||
T75856 |
Huwentoxin-IV TFA
|
||
Huwentoxin-IV TFA是一种具有高效性和选择性的钠通道阻滞剂,能够抑制Nav1.7、Nav1.2、Nav1.3和Nav1.4神经元,其IC50分别为26、150、338和400nM。通过优先结合于神经毒素受体位点4,Huwentoxin-IV TFA特异性地阻断周围神经的Nav1.7亚型。该化合物适用于炎症性及神经性疼痛动物模型的研究。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2173 |
Veratridine
|
Sodium Channel | Membrane transporter/Ion channel |
Veratridine 是一种生物碱,来自百合科植物。Veratridine 是一种钠通道激动剂, 对 Nav1.7 的峰值电流具有抑制作用,IC50为 18.39 µM。 | |||
TN1254 |
3'-Methoxydaidzein
3'-甲氧基大豆苷元 |
Sodium Channel | Membrane transporter/Ion channel |
3'-Methoxydaidzein 是一种异黄酮和 Sodium Channel 双重抑制剂。3'-Methoxydaidzein 对NaV1.7、NaV1.8 和 NaV1.3有抑制作用,IC50 分别为 181 nM、397 nM 和 505 nM。 3'-Methoxydaidzein 对胶原诱导的血小板聚集具有特异性,IC50值分别为12.3和61.5µM。。3'-Methoxydaidzein 通过抑制电压门控钠通道发挥镇痛作用。 3'-Methoxydaidzein 具有抗氧化活性和抗血小板聚集活性。 | |||
T82764 |
Cd1a
β-TRTX-cd1a,β-Theraphotoxin-cd1a |
||
Cd1a是从非洲蜘蛛Ceratogyrus darlingi中提取的β-毒素,具有调节钙离子通道的功能。它能够抑制人类的钙离子通道(Cav2.2)(IC50 2.6 μM)以及小鼠的钠离子通道(Nav1.7),有望用于开发治疗外周疼痛的药物。 |